MYDFRIN

This brand name is authorized in Canada, Singapore, Turkey

Active ingredients

The drug MYDFRIN contains one active pharmaceutical ingredient (API):

1 Phenylephrine UNII 04JA59TNSJ - PHENYLEPHRINE HYDROCHLORIDE

Phenylephrine is a sympathomimetic agent with mainly direct effects on adrenergic receptors. It has predominantly alpha adrenergic activity and is without stimulating effects on the central nervous system. The sympathomimetic effect of phenylephrine produces vasoconstriction which in turn relieves nasal congestion. Read about Phenylephrine

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
MYDFRIN 2.5% w/v Ophthalmic solution	Health Products and Food Branch (CA)	MPI, CA: SPM

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
S01FB01	Phenylephrine	S Sensory organs → S01 Ophthalmologicals → S01F Mydriatics and cycloplegics → S01FB Sympathomimetics excl. antiglaucoma preparations
Discover more medicines within S01FB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 00465763
Country: SG	Health Sciences Authority	Identifier(s): 04893P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699760610301